Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001780936 | SCV002024088 | likely pathogenic | Spondylocostal dysostosis 1, autosomal recessive | 2021-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868860 | SCV002219277 | pathogenic | not provided | 2023-10-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile123Glyfs*5) in the DLL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLL3 are known to be pathogenic (PMID: 12746394). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DLL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1324231). For these reasons, this variant has been classified as Pathogenic. |